How well do aliskiren's purported mechanisms track its effects on cardiovascular and renal disorders?
Keywords: ACE; angiotensin converting enzyme; Ang-II; angiotensin-II; Aog; angiotensinogen; ARB; Ang-II type 1 (AT1) receptor blocker; eNOS; endothelial nitric oxide synthase; HCTZ; hydrochlorothiazide; HRP; handle region peptide; JNK; c-Jun-N-terminal kinase; MAPK